 Colin Shearn
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 10 | 2023 | 228 | 4.040 |
Why?
| | Aldehydes | 15 | 2022 | 154 | 3.750 |
Why?
| | PTEN Phosphohydrolase | 7 | 2018 | 143 | 2.930 |
Why?
| | Protein Carbonylation | 10 | 2018 | 52 | 2.930 |
Why?
| | Liver Diseases, Alcoholic | 12 | 2019 | 87 | 2.860 |
Why?
| | Liver | 19 | 2022 | 1816 | 2.620 |
Why?
| | Ethanol | 12 | 2019 | 575 | 2.100 |
Why?
| | Glutathione Transferase | 8 | 2019 | 97 | 1.900 |
Why?
| | Antioxidants | 7 | 2023 | 564 | 1.880 |
Why?
| | Cholangitis, Sclerosing | 3 | 2023 | 75 | 1.610 |
Why?
| | Proto-Oncogene Proteins c-akt | 6 | 2016 | 420 | 1.560 |
Why?
| | Oxidative Stress | 14 | 2019 | 1178 | 1.390 |
Why?
| | Fatty Liver | 3 | 2014 | 253 | 1.180 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 290 | 1.070 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 16 | 1.030 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2019 | 227 | 0.970 |
Why?
| | Thioredoxins | 3 | 2018 | 30 | 0.960 |
Why?
| | Mice | 34 | 2023 | 15520 | 0.900 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 178 | 0.850 |
Why?
| | Abdominal Injuries | 1 | 2023 | 119 | 0.840 |
Why?
| | Protein Processing, Post-Translational | 4 | 2016 | 408 | 0.790 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 32 | 0.730 |
Why?
| | Hepatocytes | 5 | 2021 | 205 | 0.690 |
Why?
| | Peroxiredoxins | 2 | 2018 | 23 | 0.690 |
Why?
| | Bile Acids and Salts | 5 | 2023 | 179 | 0.690 |
Why?
| | Animals | 36 | 2023 | 33381 | 0.680 |
Why?
| | Liver Neoplasms | 4 | 2019 | 527 | 0.670 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 83 | 0.660 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 13 | 0.660 |
Why?
| | Parenteral Nutrition | 4 | 2023 | 92 | 0.650 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 105 | 0.630 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2017 | 280 | 0.620 |
Why?
| | Liver Diseases | 2 | 2021 | 282 | 0.620 |
Why?
| | Hepatitis | 1 | 2017 | 46 | 0.610 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 226 | 0.590 |
Why?
| | Superoxide Dismutase | 5 | 2019 | 339 | 0.580 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.570 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 73 | 0.570 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.560 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 19 | 0.550 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 421 | 0.550 |
Why?
| | Signal Transduction | 9 | 2021 | 4709 | 0.510 |
Why?
| | Mice, Inbred C57BL | 14 | 2021 | 4908 | 0.510 |
Why?
| | Alcoholism | 3 | 2018 | 717 | 0.510 |
Why?
| | Oxidants | 2 | 2012 | 122 | 0.480 |
Why?
| | Mice, Knockout | 8 | 2020 | 2680 | 0.480 |
Why?
| | Diet, High-Fat | 2 | 2016 | 247 | 0.460 |
Why?
| | Disease Models, Animal | 10 | 2021 | 3730 | 0.440 |
Why?
| | Dietary Fats | 2 | 2018 | 322 | 0.410 |
Why?
| | RNA, Messenger | 6 | 2023 | 2657 | 0.410 |
Why?
| | Lipid Peroxidation | 4 | 2016 | 156 | 0.410 |
Why?
| | Xenobiotics | 1 | 2011 | 25 | 0.400 |
Why?
| | Male | 27 | 2022 | 57801 | 0.390 |
Why?
| | Liver Cirrhosis | 2 | 2023 | 245 | 0.380 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 355 | 0.380 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 305 | 0.380 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 20 | 0.370 |
Why?
| | Alcohol Drinking | 1 | 2016 | 652 | 0.370 |
Why?
| | Cell Proliferation | 3 | 2018 | 2275 | 0.370 |
Why?
| | Glutathione Reductase | 3 | 2019 | 22 | 0.360 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2021 | 195 | 0.360 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2023 | 1171 | 0.360 |
Why?
| | Mitochondria | 4 | 2019 | 786 | 0.360 |
Why?
| | Inflammation | 5 | 2023 | 2566 | 0.350 |
Why?
| | Down-Regulation | 1 | 2011 | 627 | 0.330 |
Why?
| | Carcinoma | 1 | 2010 | 204 | 0.330 |
Why?
| | Blotting, Western | 4 | 2016 | 1194 | 0.320 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 57 | 0.320 |
Why?
| | Colonic Neoplasms | 1 | 2010 | 224 | 0.310 |
Why?
| | Carcinogens | 1 | 2008 | 108 | 0.310 |
Why?
| | Catalase | 2 | 2017 | 123 | 0.310 |
Why?
| | Autophagy | 2 | 2022 | 315 | 0.290 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 57 | 0.290 |
Why?
| | NF-kappa B | 2 | 2021 | 670 | 0.280 |
Why?
| | Glutathione | 4 | 2019 | 324 | 0.280 |
Why?
| | Hep G2 Cells | 3 | 2021 | 73 | 0.270 |
Why?
| | Alanine Transaminase | 3 | 2016 | 152 | 0.270 |
Why?
| | Case-Control Studies | 3 | 2018 | 3171 | 0.270 |
Why?
| | Humans | 27 | 2023 | 118974 | 0.260 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 811 | 0.260 |
Why?
| | Up-Regulation | 2 | 2019 | 872 | 0.260 |
Why?
| | Biomarkers | 1 | 2015 | 3588 | 0.260 |
Why?
| | Proteomics | 4 | 2019 | 876 | 0.260 |
Why?
| | Recombinant Proteins | 4 | 2020 | 1308 | 0.250 |
Why?
| | Macrophage Activation | 2 | 2023 | 168 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2445 | 0.250 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 827 | 0.250 |
Why?
| | Epithelial Cells | 1 | 2010 | 963 | 0.240 |
Why?
| | Lipoproteins | 2 | 2021 | 162 | 0.240 |
Why?
| | Phosphorylation | 3 | 2014 | 1633 | 0.240 |
Why?
| | Genes, Regulator | 1 | 2023 | 33 | 0.240 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 16 | 0.230 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 50 | 0.230 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 179 | 0.220 |
Why?
| | Prostatic Neoplasms | 1 | 2010 | 940 | 0.220 |
Why?
| | Insulin Resistance | 1 | 2011 | 1180 | 0.220 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2013 | 62 | 0.220 |
Why?
| | Triglycerides | 2 | 2016 | 519 | 0.210 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 70 | 0.210 |
Why?
| | Enzyme Activation | 3 | 2013 | 828 | 0.210 |
Why?
| | Dioxanes | 1 | 2021 | 8 | 0.210 |
Why?
| | Oxidation-Reduction | 3 | 2019 | 940 | 0.210 |
Why?
| | Phytosterols | 1 | 2021 | 9 | 0.200 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 150 | 0.200 |
Why?
| | Isoxazoles | 1 | 2021 | 56 | 0.200 |
Why?
| | Cholesterol | 2 | 2020 | 373 | 0.190 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 25 | 0.190 |
Why?
| | Models, Molecular | 4 | 2014 | 1435 | 0.190 |
Why?
| | Mucoproteins | 1 | 2020 | 11 | 0.190 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 133 | 0.180 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 84 | 0.180 |
Why?
| | Liposomes | 1 | 2020 | 151 | 0.180 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 180 | 0.180 |
Why?
| | Gene Expression | 2 | 2021 | 1489 | 0.170 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 490 | 0.170 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.170 |
Why?
| | Lysosomes | 1 | 2019 | 136 | 0.170 |
Why?
| | Colon | 1 | 2020 | 238 | 0.160 |
Why?
| | PPAR alpha | 2 | 2016 | 56 | 0.160 |
Why?
| | Female | 9 | 2021 | 61565 | 0.160 |
Why?
| | Ribosomes | 1 | 2019 | 142 | 0.160 |
Why?
| | Lung | 1 | 2011 | 3664 | 0.160 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 53 | 0.160 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 75 | 0.160 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.160 |
Why?
| | Colitis | 1 | 2020 | 219 | 0.160 |
Why?
| | Reactive Oxygen Species | 2 | 2011 | 576 | 0.160 |
Why?
| | Aminobutyrates | 1 | 2018 | 32 | 0.160 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 29 | 0.160 |
Why?
| | Azo Compounds | 1 | 2017 | 25 | 0.160 |
Why?
| | Organ Specificity | 1 | 2018 | 278 | 0.150 |
Why?
| | Taurine | 1 | 2018 | 46 | 0.150 |
Why?
| | Malnutrition | 1 | 2018 | 66 | 0.150 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 74 | 0.150 |
Why?
| | Protein Structure, Secondary | 1 | 2018 | 338 | 0.150 |
Why?
| | Middle Aged | 4 | 2019 | 27617 | 0.150 |
Why?
| | Homocystinuria | 1 | 2018 | 63 | 0.150 |
Why?
| | Gene Deletion | 2 | 2015 | 361 | 0.150 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1206 | 0.150 |
Why?
| | Cell Line, Tumor | 3 | 2020 | 2851 | 0.140 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2071 | 0.140 |
Why?
| | Adult | 4 | 2019 | 31512 | 0.140 |
Why?
| | Lipogenesis | 1 | 2016 | 66 | 0.140 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 86 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 248 | 0.130 |
Why?
| | Sirtuin 3 | 2 | 2019 | 60 | 0.130 |
Why?
| | Proteome | 1 | 2019 | 353 | 0.130 |
Why?
| | Acetylation | 4 | 2017 | 217 | 0.130 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 6 | 0.130 |
Why?
| | Protein Isoforms | 1 | 2015 | 345 | 0.120 |
Why?
| | CD36 Antigens | 1 | 2014 | 42 | 0.120 |
Why?
| | Protein Binding | 4 | 2020 | 1975 | 0.120 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 97 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 129 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2013 | 341 | 0.120 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 89 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 158 | 0.120 |
Why?
| | Computational Biology | 1 | 2017 | 588 | 0.110 |
Why?
| | DNA Primers | 2 | 2012 | 533 | 0.110 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 26 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2017 | 726 | 0.110 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 38 | 0.110 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 57 | 0.110 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2871 | 0.110 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 241 | 0.110 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 1012 | 0.110 |
Why?
| | Models, Chemical | 1 | 2014 | 274 | 0.110 |
Why?
| | Organ Size | 1 | 2013 | 460 | 0.100 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 25 | 0.100 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2011 | 65 | 0.100 |
Why?
| | Adiponectin | 1 | 2013 | 226 | 0.100 |
Why?
| | Peptide Mapping | 1 | 2011 | 63 | 0.100 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2011 | 83 | 0.100 |
Why?
| | Binding Sites | 2 | 2020 | 1224 | 0.100 |
Why?
| | Oxygen Consumption | 1 | 2013 | 586 | 0.090 |
Why?
| | Crotonates | 1 | 2010 | 3 | 0.090 |
Why?
| | Toluidines | 1 | 2010 | 5 | 0.090 |
Why?
| | Hydroxybutyrates | 1 | 2010 | 11 | 0.090 |
Why?
| | Fenretinide | 1 | 2010 | 4 | 0.090 |
Why?
| | Receptors, Estrogen | 1 | 2013 | 387 | 0.090 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 874 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2010 | 136 | 0.090 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 314 | 0.090 |
Why?
| | Nitriles | 1 | 2010 | 155 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 183 | 0.090 |
Why?
| | Protein Conformation | 1 | 2012 | 848 | 0.090 |
Why?
| | Glycoproteins | 1 | 2011 | 319 | 0.090 |
Why?
| | Cell Survival | 1 | 2012 | 1047 | 0.080 |
Why?
| | Alkylation | 1 | 2008 | 19 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 597 | 0.080 |
Why?
| | DNA Damage | 2 | 2021 | 357 | 0.080 |
Why?
| | Cytosol | 1 | 2008 | 221 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 564 | 0.080 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 171 | 0.080 |
Why?
| | Kidney | 1 | 2015 | 1353 | 0.080 |
Why?
| | Base Sequence | 1 | 2011 | 2159 | 0.070 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2007 | 38 | 0.070 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2220 | 0.070 |
Why?
| | Static Electricity | 1 | 2007 | 121 | 0.070 |
Why?
| | Hydrolysis | 1 | 2007 | 176 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2013 | 4077 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1691 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 276 | 0.070 |
Why?
| | Cloning, Molecular | 2 | 2020 | 546 | 0.070 |
Why?
| | Peptides | 1 | 2011 | 879 | 0.070 |
Why?
| | Skin | 1 | 2010 | 657 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 2478 | 0.070 |
Why?
| | Metabolome | 2 | 2019 | 296 | 0.070 |
Why?
| | Phospholipids | 1 | 2007 | 208 | 0.070 |
Why?
| | Transcription Factors | 1 | 2013 | 1570 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1059 | 0.060 |
Why?
| | Glycosylation | 2 | 2016 | 129 | 0.060 |
Why?
| | Amino Acids | 2 | 2018 | 465 | 0.060 |
Why?
| | Rats | 1 | 2011 | 5392 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 17 | 0.050 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2021 | 36 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 23 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 30 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 106 | 0.050 |
Why?
| | Fatty Acids | 2 | 2016 | 407 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 79 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 95 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 94 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 135 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 136 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 16 | 0.050 |
Why?
| | Sphingomyelins | 1 | 2020 | 29 | 0.050 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 22 | 0.050 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 52 | 0.050 |
Why?
| | Calcium | 1 | 2007 | 1169 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 66 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2020 | 71 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 101 | 0.050 |
Why?
| | Apoptosis | 1 | 2010 | 2484 | 0.050 |
Why?
| | Phosphatidylserines | 1 | 2020 | 91 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 311 | 0.050 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 138 | 0.050 |
Why?
| | Lipid Bilayers | 1 | 2020 | 100 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 302 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 422 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 379 | 0.040 |
Why?
| | Aged | 1 | 2017 | 19657 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 213 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 34 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 331 | 0.040 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 43 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 176 | 0.040 |
Why?
| | Cystathionine beta-Synthase | 1 | 2018 | 60 | 0.040 |
Why?
| | F2-Isoprostanes | 1 | 2016 | 17 | 0.040 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2016 | 5 | 0.040 |
Why?
| | Sumoylation | 1 | 2016 | 16 | 0.040 |
Why?
| | Escherichia coli | 1 | 2020 | 758 | 0.040 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 330 | 0.040 |
Why?
| | Oxides | 1 | 2016 | 42 | 0.040 |
Why?
| | Mutation | 1 | 2007 | 3457 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 204 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 44 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 25 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1324 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 156 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 88 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 46 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 90 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 250 | 0.030 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 144 | 0.030 |
Why?
| | Actins | 1 | 2014 | 404 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 392 | 0.030 |
Why?
| | Fibrosis | 1 | 2014 | 483 | 0.030 |
Why?
| | Ubiquitination | 1 | 2012 | 87 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2015 | 477 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2012 | 161 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 462 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 290 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2490 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 823 | 0.030 |
Why?
| | Microsomes, Liver | 1 | 2011 | 59 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 756 | 0.020 |
Why?
| | NAD | 1 | 2011 | 67 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 336 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 963 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 982 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 922 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 607 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 681 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1167 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2025 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1900 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2275 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 18480 | 0.010 |
Why?
| | Child | 1 | 2016 | 19129 | 0.010 |
Why?
|
|
Shearn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|